<i>RAD50</i> germline mutations are associated with poor survival in <i>BRCA1/2</i>–negative breast cancer patients

Cong Fan(Qilu Hospital of Shandong University), Yuntao Xie(Peking University), Juan Zhang(Central South University), Jinfeng Li(Hebei Medical University), Zhaoqing Fan(Daqing Oilfield General Hospital), Tianfeng Wang(Peking University), Tie Fan(Ministry of Education), Benyao Lin(Ministry of Education), Tao Ouyang(Peking University)
International Journal of Cancer
May 4, 2018
Cited by 45


Related Papers